Synopsis
0
CEP/COS
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharm-RX Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Bioplus Life Sciences
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Valens Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Zhejiang Huakang Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Film Formers & Plasticizers
Taste Masking
Topical
Thickeners and Stabilizers
Fillers, Diluents & Binders
Coating Systems & Additives
Parenteral
Solubilizers
API Stability Enhancers
Direct Compression
Rheology Modifiers
Chewable & Orodispersible Aids
Lubricants & Glidants
Soft Gelatin
Co-Processed Excipients
Emulsifying Agents
Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
ABOUT THIS PAGE
53
PharmaCompass offers a list of Calcium Polystyrene Sulfonate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Calcium Polystyrene Sulfonate manufacturer or Calcium Polystyrene Sulfonate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Calcium Polystyrene Sulfonate manufacturer or Calcium Polystyrene Sulfonate supplier.
PharmaCompass also assists you with knowing the Calcium Polystyrene Sulfonate API Price utilized in the formulation of products. Calcium Polystyrene Sulfonate API Price is not always fixed or binding as the Calcium Polystyrene Sulfonate Price is obtained through a variety of data sources. The Calcium Polystyrene Sulfonate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Kayexalate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Kayexalate, including repackagers and relabelers. The FDA regulates Kayexalate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Kayexalate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Kayexalate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Kayexalate supplier is an individual or a company that provides Kayexalate active pharmaceutical ingredient (API) or Kayexalate finished formulations upon request. The Kayexalate suppliers may include Kayexalate API manufacturers, exporters, distributors and traders.
click here to find a list of Kayexalate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Kayexalate DMF (Drug Master File) is a document detailing the whole manufacturing process of Kayexalate active pharmaceutical ingredient (API) in detail. Different forms of Kayexalate DMFs exist exist since differing nations have different regulations, such as Kayexalate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Kayexalate DMF submitted to regulatory agencies in the US is known as a USDMF. Kayexalate USDMF includes data on Kayexalate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Kayexalate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Kayexalate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Kayexalate Drug Master File in Japan (Kayexalate JDMF) empowers Kayexalate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Kayexalate JDMF during the approval evaluation for pharmaceutical products. At the time of Kayexalate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Kayexalate suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Kayexalate Drug Master File in Korea (Kayexalate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Kayexalate. The MFDS reviews the Kayexalate KDMF as part of the drug registration process and uses the information provided in the Kayexalate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Kayexalate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Kayexalate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Kayexalate suppliers with KDMF on PharmaCompass.
A Kayexalate written confirmation (Kayexalate WC) is an official document issued by a regulatory agency to a Kayexalate manufacturer, verifying that the manufacturing facility of a Kayexalate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Kayexalate APIs or Kayexalate finished pharmaceutical products to another nation, regulatory agencies frequently require a Kayexalate WC (written confirmation) as part of the regulatory process.
click here to find a list of Kayexalate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Kayexalate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Kayexalate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Kayexalate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Kayexalate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Kayexalate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Kayexalate suppliers with NDC on PharmaCompass.
Kayexalate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Kayexalate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Kayexalate GMP manufacturer or Kayexalate GMP API supplier for your needs.
A Kayexalate CoA (Certificate of Analysis) is a formal document that attests to Kayexalate's compliance with Kayexalate specifications and serves as a tool for batch-level quality control.
Kayexalate CoA mostly includes findings from lab analyses of a specific batch. For each Kayexalate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Kayexalate may be tested according to a variety of international standards, such as European Pharmacopoeia (Kayexalate EP), Kayexalate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Kayexalate USP).
